EPO is a peptide hormone that is produced naturally by the human body. It is released from the kidneys and acts on the bone marrow to stimulate red blood cell production. By injecting EPO, athletes aim to increase the concentration of red blood cells
“This new peak in European patent filings for the third year in a row shows that companies from Europe and nearly the world are continuing to seek out protection for their inventions, and that Europe remains an attractive market for new technologies,” said
The knock-on effect of the Lance Armstrong cycling scandal continues to be felt in the Netherlands with the NRC reporting on Saturday that doping was widespread in the professional cycling team sponsored by Rabobank. The paper says the team used
In 2012, the European Patent Office (EPO) received 258 000 patent applications. This represents a 5.7% increase over 2011 (244 000) and sets a new record. In the constant year, the EPO published 65 700 granted patents, 5.8% more than in 2011 (62 115).
The European Patent Office Administrative Council in December agreed to choice a controversial bonus of tens of millions of euros to EPO staff at the end of 2012, with 24 positive votes and 8 negative votes. Several
Related External Links
My cocktail was EPO: Lance Armstrong
No comments:
Post a Comment